White label ELPA - ClinicalTrials.eu

Study on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
- (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
- Ribociclib
Study on Ustekinumab for Children with Moderate to Severe Crohn’s Disease

Not recruiting

3 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Ustekinumab
Study on Fluorescence-Guided Surgery for Colorectal Liver Metastases Using SGM-101 and Indocyanine Green for Patients with Colorectal Cancer

Not recruiting

2 1 1
Investigated diseases:
- Metastases to liver
Investigated drugs:
- Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Not recruiting

3 1 1 1
Investigated diseases:
- Marginal zone lymphoma
Investigated drugs:
+8
Study on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis

Not recruiting

2 1 1
Investigated diseases:
- Relapsing multiple sclerosis
Investigated drugs:
+1
Study of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- 1,3,5-Tris(6-Methylpyridin-2-Yloxy)Benzene
Study on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis

Not recruiting

2 1
Investigated diseases:
- Psoriasis
Investigated drugs:
- Dc-806
Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

Not recruiting

1 1 1 1
Investigated drugs:
- Nivolumab
- Relatlimab
Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

2 1
Investigated diseases:
- Hidradenitis
Investigated drugs:
- Sar442970
+5
Study on Valaciclovir to Prevent Congenital CMV Infection in Pregnant Women with First Trimester CMV Infections

Not recruiting

3 1 1 1
Investigated diseases:
- Cytomegalovirus infection
Investigated drugs:
- Valaciclovir

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies